Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
saccharomyces boulardii (Biocodex)
- Development stage
- Unknown
- Lead developer
- Takgene Biopharma
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
**Bioflora** is an oral probiotic medicinal product containing lyophilized *Saccharomyces boulardii* CNCM I-745, a live nonpathogenic yeast. It is marketed by Biocodex for treatment of acute infectious diarrhea alongside oral rehydration therapy, prevention of antibiotic-associated diarrhea, and prevention of recurrent diarrhea associated with *Clostridioides difficile* infection. The Bioflora product range includes 200 mg capsules and 100 mg powder for oral suspension sachets. ([biocodex.vn](https://www.biocodex.vn/wp-content/uploads/sites/15/2025/03/Bioflora-100-leaflet-EN.pdf))
- Brand names
- Bioflora
- Other names
- Saccharomyces boulardiiSaccharomyces boulardii CNCM I-745
Beyond the preview
Go deeper on saccharomyces boulardii (Biocodex).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on saccharomyces boulardii (Biocodex).